tosyllysine chloromethyl ketone has been researched along with Scleroderma, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kahaleh, MB; Leroy, EC | 1 |
| Kahaleh, MB; LeRoy, EC; Mercurio, S | 1 |
2 other study(ies) available for tosyllysine chloromethyl ketone and Scleroderma, Systemic
| Article | Year |
|---|---|
Endothelial injury in scleroderma. A protease mechanism.
Topics: Cells, Cultured; Endothelium; Fibroblasts; Humans; Peptide Hydrolases; Phenylmethylsulfonyl Fluoride; Protease Inhibitors; Scleroderma, Systemic; Thymidine; Tosyllysine Chloromethyl Ketone; Trypsin Inhibitor, Kunitz Soybean | 1983 |
A fibroblast mitogen present in scleroderma but not control sera: inhibition by proteinase inhibitors.
Topics: Animals; Cattle; Fibroblasts; Humans; Mitogens; Protease Inhibitors; Scleroderma, Systemic; Tosyllysine Chloromethyl Ketone; Trypsin Inhibitors | 1983 |